Data:
{
"symbol": "BBIO",
"price": 72.327,
"marketCap": 14166056050,
"beta": 0.971,
"lastDividend": 0,
"range": "48.78-93.415",
"change": -0.173,
"changePercentage": -0.23862,
"volume": 606589.54951,
"averageVolume": 2983847,
"companyName": "BridgeBio Pharma, Inc.",
"currency": "USD",
"cik": "0001743881",
"isin": "US10806X1028",
"cusip": "10806X102",
"exchangeFullName": "NASDAQ Global Select",
"exchange": "NASDAQ",
"industry": "Biotechnology",
"website": "https://www.bridgebio.com",
"description": "BridgeBio Pharma, Inc. is a pharmaceutical company dedicated to identifying, advancing, and providing medical solutions for various genetic conditions. The firm boasts an extensive portfolio comprising 30 distinct development initiatives, spanning the entire spectrum from initial discovery research to advanced clinical trial phases. Notable candidates within its development pipeline include: AG10 and BBP-265: A small molecule designed to stabilize transthyretin (TTR), currently in a pivotal Phase 3 clinical trial targeting transthyretin amyloidosis-cardiomyopathy (ATTR-CM). BBP-831: A selective small molecule inhibitor of FGFR1-3, which is undergoing Phase 2 clinical evaluation for treating achondroplasia in pediatric patients. BBP-631: An AAV5 gene transfer product candidate, also in Phase 2 clinical trials, aimed at congenital adrenal hyperplasia (CAH) caused by 21-hydroxylase deficiency (21OHD). Furthermore, BridgeBio is developing: Encaleret: A small molecule antagonist of the calcium sensing receptor (CaSR), presently in a Phase 2 proof-of-concept study for Autosomal Dominant Hypocalcemia Type 1 (ADH1). BBP-711: Intended for the management of hyperoxaluria and individuals prone to recurring kidney stones. Beyond these specific programs, the company is actively engaged in developing therapies for a broader range of Mendelian disorders, oncological diseases, and gene therapy applications. BridgeBio Pharma, Inc. maintains strategic licensing and collaboration agreements with institutions such as Leland Stanford Junior University, The Regents of the University of California, and Leidos Biomedical Research, Inc. Established in 2015, the company's corporate headquarters are situated in Palo Alto, California.",
"ceo": "Neil Kumar",
"sector": "Healthcare",
"country": "US",
"fullTimeEmployees": "999",
"phone": "650 391 9740",
"address": "3160 Porter Drive",
"city": "Palo Alto",
"state": "CA",
"zip": "94304",
"image": "https://images.financialmodelingprep.com/symbol/BBIO.png",
"ipoDate": "2019-06-27",
"defaultImage": false,
"isEtf": false,
"isActivelyTrading": true,
"isAdr": false,
"isFund": false
}
Data:
{
"symbol": "BBIO",
"name": "BridgeBio Pharma, Inc.",
"price": 72.44,
"changePercentage": -0.08275862,
"change": -0.06,
"volume": 1748654,
"dayLow": 71.985,
"dayHigh": 74.105,
"yearHigh": 93.415,
"yearLow": 48.78,
"marketCap": 14188188370,
"priceAvg50": 80.7348,
"priceAvg200": 73.97952,
"exchange": "NASDAQ",
"open": 73.225,
"previousClose": 72.5,
"timestamp": 1789156801,
"quote_spread": {},
"chart_vwap_daily": [
{
"t": "2026-07-31",
"v": 80.2845,
"c": 80.09
},
{
"t": "2026-08-03",
"v": 80.0878,
"c": 79.96
},
{
"t": "2026-08-04",
"v": 81.6106,
"c": 82.07
},
{
"t": "2026-08-05",
"v": 82.0392,
"c": 81.99
},
{
"t": "2026-08-06",
"v": 82.8928,
"c": 82.8
},
{
"t": "2026-08-07",
"v": 83.9074,
"c": 84.48
},
{
"t": "2026-08-10",
"v": 84.913,
"c": 84.67
},
{
"t": "2026-08-11",
"v": 84.4538,
"c": 83.7
},
{
"t": "2026-08-12",
"v": 84.0654,
"c": 83.84
},
{
"t": "2026-08-13",
"v": 81.5431,
"c": 81.21
},
{
"t": "2026-08-14",
"v": 79.7139,
"c": 79.86
},
{
"t": "2026-08-17",
"v": 79.5037,
"c": 79.89
},
{
"t": "2026-08-18",
"v": 82.5401,
"c": 82.98
},
{
"t": "2026-08-19",
"v": 83.9953,
"c": 83.95
},
{
"t": "2026-08-20",
"v": 83.2866,
"c": 82.94
},
{
"t": "2026-08-21",
"v": 82.0926,
"c": 81.5
},
{
"t": "2026-08-24",
"v": 80.9028,
"c": 81.07
},
{
"t": "2026-08-25",
"v": 80.6949,
"c": 80.4
},
{
"t": "2026-08-26",
"v": 79.7196,
"c": 79.37
},
{
"t": "2026-08-27",
"v": 78.7181,
"c": 78.68
},
{
"t": "2026-08-28",
"v": 77.5458,
"c": 76.6
},
{
"t": "2026-08-31",
"v": 76.1918,
"c": 76.59
},
{
"t": "2026-09-01",
"v": 76.6041,
"c": 76.57
},
{
"t": "2026-09-02",
"v": 76.5112,
"c": 76.5
},
{
"t": "2026-09-03",
"v": 75.5485,
"c": 75.41
},
{
"t": "2026-09-04",
"v": 74.538,
"c": 74.84
},
{
"t": "2026-09-08",
"v": 74.6455,
"c": 74.76
},
{
"t": "2026-09-09",
"v": 75.7426,
"c": 76.08
},
{
"t": "2026-09-10",
"v": 72.9862,
"c": 72.5
},
{
"t": "2026-09-11",
"v": 72.4784,
"c": 72.44
}
],
"vwap_summary": {
"days": 30,
"days_above": 10,
"days_below": 20,
"pct_days_above": 33,
"position": "below",
"gap_pct": -0.05,
"streak_days": 2
}
}
Data:
{
"volume": 1748654,
"avgVolume": 2983847,
"short_ratio": [
{
"symbol": "BBIO",
"file_date": "2026-09-10",
"date": "20260910",
"short_volume": 549570,
"short_exempt_volume": 381,
"total_volume": 1377918,
"short_volume_ratio": 0.3988,
"signal": "Bullish"
}
],
"volume_profile": {
"poc": 76.61,
"vah": 80.46,
"val": 72.11,
"profile": [
{
"price": 72.22,
"volume": 744393
},
{
"price": 72.44,
"volume": 749168
},
{
"price": 72.66,
"volume": 1081285
},
{
"price": 72.88,
"volume": 265266
},
{
"price": 73.1,
"volume": 208096
},
{
"price": 73.32,
"volume": 182109
},
{
"price": 73.54,
"volume": 170252
},
{
"price": 73.76,
"volume": 73751
},
{
"price": 73.98,
"volume": 92238
},
{
"price": 74.2,
"volume": 649572
},
{
"price": 74.41,
"volume": 1197804
},
{
"price": 74.63,
"volume": 664285
},
{
"price": 74.85,
"volume": 760455
},
{
"price": 75.07,
"volume": 170982
},
{
"price": 75.29,
"volume": 628530
},
{
"price": 75.51,
"volume": 463630
},
{
"price": 75.73,
"volume": 402279
},
{
"price": 75.95,
"volume": 1106689
},
{
"price": 76.17,
"volume": 1111081
},
{
"price": 76.39,
"volume": 585965
},
{
"price": 76.61,
"volume": 1551832
},
{
"price": 76.83,
"volume": 397027
},
{
"price": 77.05,
"volume": 363410
},
{
"price": 77.27,
"volume": 104375
},
{
"price": 77.49,
"volume": 40396
},
{
"price": 77.71,
"volume": 0
},
{
"price": 77.93,
"volume": 27721
},
{
"price": 78.15,
"volume": 122812
},
{
"price": 78.37,
"volume": 177719
},
{
"price": 78.59,
"volume": 596752
},
{
"price": 78.81,
"volume": 875692
},
{
"price": 79.03,
"volume": 467593
},
{
"price": 79.25,
"volume": 472655
},
{
"price": 79.47,
"volume": 859122
},
{
"price": 79.69,
"volume": 1433873
},
{
"price": 79.91,
"volume": 1362784
},
{
"price": 80.13,
"volume": 1040869
},
{
"price": 80.35,
"volume": 978927
},
{
"price": 80.57,
"volume": 452972
},
{
"price": 80.79,
"volume": 141276
},
{
"price": 81.0,
"volume": 469701
},
{
"price": 81.22,
"volume": 316374
},
{
"price": 81.44,
"volume": 224915
},
{
"price": 81.66,
"volume": 84709
},
{
"price": 81.88,
"volume": 445781
},
{
"price": 82.1,
"volume": 820018
},
{
"price": 82.32,
"volume": 329559
},
{
"price": 82.54,
"volume": 620825
},
{
"price": 82.76,
"volume": 408300
},
{
"price": 82.98,
"volume": 909792
},
{
"price": 83.2,
"volume": 730291
},
{
"price": 83.42,
"volume": 517417
},
{
"price": 83.64,
"volume": 633558
},
{
"price": 83.86,
"volume": 439738
},
{
"price": 84.08,
"volume": 618969
},
{
"price": 84.3,
"volume": 518786
},
{
"price": 84.52,
"volume": 89306
},
{
"price": 84.74,
"volume": 15466
},
{
"price": 84.96,
"volume": 108575
},
{
"price": 85.18,
"volume": 49151
}
],
"sessions": 20
}
}
Data:
{
"symbol": "BBIO",
"marketCap": 14188188370,
"enterpriseValueTTM": 16004053370,
"evToSalesTTM": 23.1327605137063,
"evToOperatingCashFlowTTM": -27.282457680282846,
"evToFreeCashFlowTTM": -27.02834956030946,
"evToEBITDATTM": -26.551022071583336,
"netDebtToEBITDATTM": -3.012553793677812,
"currentRatioTTM": 1.2273513217342877,
"incomeQualityTTM": 0.8434888389133973,
"grahamNumberTTM": null,
"grahamNetNetTTM": -14.22854366763234,
"taxBurdenTTM": 0.9859438149103752,
"interestBurdenTTM": 1.1457521408846503,
"workingCapitalTTM": 202490000,
"investedCapitalTTM": 251436000,
"returnOnAssetsTTM": -0.5719547950010638,
"operatingReturnOnAssetsTTM": -0.4199483827097532,
"returnOnTangibleAssetsTTM": -0.5847522966292588,
"returnOnEquityTTM": 0.3166979787100848,
"returnOnInvestedCapitalTTM": -0.6176899213693888,
"returnOnCapitalEmployedTTM": -1.6637695889496742,
"earningsYieldTTM": -0.04909069182308506,
"freeCashFlowYieldTTM": -0.04173337599971546,
"capexToOperatingCashFlowTTM": -0.009401540386562702,
"capexToDepreciationTTM": 0.8362395754359363,
"capexToRevenueTTM": 0.007971553910975883,
"salesGeneralAndAdministrativeToRevenueTTM": 0.968118120650155,
"researchAndDevelopementToRevenueTTM": 0.7674633402473133,
"stockBasedCompensationToRevenueTTM": 0.16182037624578113,
"intangiblesToTotalAssetsTTM": 0.021885337949016634,
"averageReceivablesTTM": 229855000,
"averagePayablesTTM": 28130000,
"averageInventoryTTM": 42911000,
"daysOfSalesOutstandingTTM": 134.26129062565496,
"daysOfPayablesOutstandingTTM": 209.23733456967042,
"daysOfInventoryOutstandingTTM": 406.45979094664085,
"operatingCycleTTM": 540.7210815722958,
"cashConversionCycleTTM": 331.48374700262536,
"freeCashFlowToEquityTTM": 3937000,
"freeCashFlowToFirmTTM": -500385540.81334984,
"tangibleAssetValueTTM": -2532534000,
"netCurrentAssetValueTTM": -2630054000,
"grossProfitMarginTTM": 0.9314113914444918,
"ebitMarginTTM": -0.8908684874283608,
"ebitdaMarginTTM": -0.871256874832872,
"operatingProfitMarginTTM": -0.7855514681968967,
"pretaxProfitMarginTTM": -1.0207144767177145,
"continuousOperationsProfitMarginTTM": -1.0184812852775589,
"netProfitMarginTTM": -1.0063671251093107,
"bottomLineProfitMarginTTM": -1.0063671251093107,
"receivablesTurnoverTTM": 2.7185795570644915,
"payablesTurnoverTTM": 1.7444305565767222,
"inventoryTurnoverTTM": 0.8979978047765036,
"fixedAssetTurnoverTTM": 31.017036538892626,
"assetTurnoverTTM": 0.5683361277714021,
"quickRatioTTM": 1.1680214854802347,
"solvencyRatioTTM": -0.18335664666232632,
"cashRatioTTM": 0.7611435718712668,
"priceToEarningsRatioTTM": -20.23463687150838,
"priceToEarningsGrowthRatioTTM": -1.569567384211479,
"forwardPriceToEarningsGrowthRatioTTM": 0.1960539572906838,
"priceToEarningsDilutedRatioTTM": -20.23463687150838,
"priceToEarningsDilutedGrowthRatioTTM": -1.569567384211479,
"priceToBookRatioTTM": -5.638774195033029,
"priceToSalesRatioTTM": 20.508052310160657,
"priceToFreeCashFlowRatioTTM": -23.96163684449631,
"priceToOperatingCashFlowRatioTTM": -24.17760717919694,
"debtToAssetsRatioTTM": 2.0486141859970313,
"debtToEquityRatioTTM": -0.9914762753879887,
"debtToCapitalRatioTTM": -116.3196044591632,
"longTermDebtToCapitalRatioTTM": -3.2798911656303917,
"financialLeverageRatioTTM": -0.48397413342398166,
"workingCapitalTurnoverRatioTTM": 2.451099183362562,
"operatingCashFlowRatioTTM": -0.6586283245457241,
"operatingCashFlowSalesRatioTTM": -0.8478987041707922,
"freeCashFlowOperatingCashFlowRatioTTM": 1.0094015403865626,
"debtServiceCoverageRatioTTM": -0.9426673795483446,
"interestCoverageRatioTTM": -6.049870870068572,
"shortTermOperatingCashFlowCoverageRatioTTM": -1.070536814154447,
"operatingCashFlowCoverageRatioTTM": -0.23522802368777307,
"capitalExpenditureCoverageRatioTTM": -106.36554850407978,
"dividendPaidAndCapexCoverageRatioTTM": -106.36554850407978,
"dividendPayoutRatioTTM": 0,
"dividendYieldTTM": 0,
"revenuePerShareTTM": 3.5336306472431893,
"netIncomePerShareTTM": -3.5561297156642815,
"interestDebtPerShareTTM": 13.196089254320297,
"cashPerShareTTM": 3.6783039986682593,
"bookValuePerShareTTM": -12.79915052507054,
"tangibleBookValuePerShareTTM": -12.935222643528274,
"shareholdersEquityPerShareTTM": -12.846763763622508,
"operatingCashFlowPerShareTTM": -2.9961608468156977,
"capexPerShareTTM": 0.028168527205975687,
"freeCashFlowPerShareTTM": -3.0243293740216735,
"netIncomePerEBTTTM": 0.9859438149103752,
"ebtPerEbitTTM": 1.2993604086319075,
"priceToFairValueTTM": -5.638774195033029,
"debtToMarketCapTTM": 0.1744752702349412,
"effectiveTaxRateTTM": 0.002187870840567232,
"enterpriseValueMultipleTTM": -26.551022071583336,
"dividendPerShareTTM": 0,
"revenue_history": [
{
"date": "2025",
"revenue": 502078000
}
],
"dcf": {
"symbol": "BBIO",
"date": "2026-09-11",
"dcf": -129.18055542628323,
"Stock Price": 72.415
},
"statements": {
"income": [
{
"date": "2025-12-31",
"symbol": "BBIO",
"reportedCurrency": "USD",
"cik": "0001743881",
"filingDate": "2026-02-24",
"acceptedDate": "2026-02-24 16:51:59",
"fiscalYear": "2025",
"period": "FY",
"revenue": 502078000,
"costOfRevenue": 28273000,
"grossProfit": 473805000,
"researchAndDevelopmentExpenses": 477536000,
"generalAndAdministrativeExpenses": 0,
"sellingAndMarketingExpenses": 0,
"sellingGeneralAndAdministrativeExpenses": 555140000,
"otherExpenses": 10216000,
"operatingExpenses": 1042892000,
"costAndExpenses": 1071165000,
"netInterestIncome": -33249000,
"interestIncome": 19854000,
"interestExpense": 53103000,
"depreciationAndAmortization": 8999000,
"ebitda": -672884000,
"ebit": -681883000,
"nonOperatingIncomeExcludingInterest": 112796000,
"operatingIncome": -569087000,
"totalOtherIncomeExpensesNet": -165899000,
"incomeBeforeTax": -734986000,
"incomeTaxExpense": 555000,
"netIncomeFromContinuingOperations": -735541000,
"netIncomeFromDiscontinuedOperations": 0,
"otherAdjustmentsToNetIncome": 0,
"netIncome": -729306000,
"netIncomeDeductions": 0,
"bottomLineNetIncome": -729306000,
"eps": -3.79,
"epsDiluted": -3.79,
"weightedAverageShsOut": 197238000,
"weightedAverageShsOutDil": 197238000
}
],
"balance_sheet": [
{
"date": "2025-12-31",
"symbol": "BBIO",
"reportedCurrency": "USD",
"cik": "0001743881",
"filingDate": "2026-02-24",
"acceptedDate": "2026-02-24 16:51:59",
"fiscalYear": "2025",
"period": "FY",
"cashAndCashEquivalents": 570119000,
"shortTermInvestments": 17363000,
"cashAndShortTermInvestments": 587482000,
"netReceivables": 139444000,
"accountsReceivables": 139444000,
"otherReceivables": 0,
"inventory": 26753000,
"prepaids": 0,
"otherCurrentAssets": 0,
"totalCurrentAssets": 753679000,
"propertyPlantEquipmentNet": 13515000,
"goodwill": 0,
"intangibleAssets": 28077000,
"goodwillAndIntangibleAssets": 28077000,
"longTermInvestments": 81443000,
"taxAssets": 0,
"otherNonCurrentAssets": -81443000,
"totalNonCurrentAssets": 41592000,
"otherAssets": 140754000,
"totalAssets": 936025000,
"totalPayables": 36228000,
"accountPayables": 36228000,
"otherPayables": 0,
"accruedExpenses": 0,
"shortTermDebt": 17413000,
"capitalLeaseObligationsCurrent": 0,
"taxPayables": 0,
"deferredRevenue": 20270000,
"otherCurrentLiabilities": 214060000,
"totalCurrentLiabilities": 287971000,
"longTermDebt": 2707500000,
"capitalLeaseObligationsNonCurrent": 3811000,
"deferredRevenueNonCurrent": 13080000,
"deferredTaxLiabilitiesNonCurrent": 0,
"otherNonCurrentLiabilities": 244000,
"totalNonCurrentLiabilities": 2724635000,
"otherLiabilities": 0,
"capitalLeaseObligations": 3811000,
"totalLiabilities": 3012606000,
"treasuryStock": -323276000,
"preferredStock": 0,
"commonStock": 202000,
"retainedEarnings": -3821194000,
"additionalPaidInCapital": 2057646000,
"accumulatedOtherComprehensiveIncomeLoss": 12000,
"otherTotalStockholdersEquity": 0,
"totalStockholdersEquity": -2076581000,
"totalEquity": -2077151000,
"minorityInterest": -570000,
"totalLiabilitiesAndTotalEquity": 936025000,
"totalInvestments": 98806000,
"totalDebt": 2728724000,
"netDebt": 2158605000
}
],
"cash_flow": [
{
"date": "2025-12-31",
"symbol": "BBIO",
"reportedCurrency": "USD",
"cik": "0001743881",
"filingDate": "2026-02-24",
"acceptedDate": "2026-02-24 16:51:59",
"fiscalYear": "2025",
"period": "FY",
"netIncome": -724931000,
"depreciationAndAmortization": 5967000,
"deferredIncomeTax": 0,
"stockBasedCompensation": 133024000,
"changeInWorkingCapital": -51064000,
"accountsReceivables": -134722000,
"inventory": -25307000,
"accountsPayables": 26609000,
"otherWorkingCapital": 82356000,
"otherNonCashItems": 191094000,
"netCashProvidedByOperatingActivities": -445910000,
"investmentsInPropertyPlantAndEquipment": -1097000,
"acquisitionsNet": 0,
"purchasesOfInvestments": -28197000,
"salesMaturitiesOfInvestments": 11000000,
"otherInvestingActivities": -6193000,
"netCashProvidedByInvestingActivities": -24487000,
"netDebtIssuance": 385496000,
"longTermNetDebtIssuance": 385496000,
"shortTermNetDebtIssuance": 0,
"netStockIssuance": -14127000,
"netCommonStockIssuance": -14127000,
"commonStockIssuance": 34149000,
"commonStockRepurchased": -48276000,
"netPreferredStockIssuance": 0,
"netDividendsPaid": 0,
"commonDividendsPaid": 0,
"preferredDividendsPaid": 0,
"otherFinancingActivities": -12076000,
"netCashProvidedByFinancingActivities": 359293000,
"effectOfForexChangesOnCash": 0,
"netChangeInCash": -111104000,
"cashAtEndOfPeriod": 572140000,
"cashAtBeginningOfPeriod": 683244000,
"operatingCashFlow": -445910000,
"capitalExpenditure": -1097000,
"freeCashFlow": -447007000,
"incomeTaxesPaid": 0,
"interestPaid": 0
}
]
}
}
Data:
{
"price": 72.44,
"rsi": 29.893313178739902,
"sma20": 78.14650000000003,
"sma50": 80.69319999999995,
"sma200": 74.00124999999991,
"adx": 17.046777247735044,
"atr": 2.27,
"atr_pct": 3.13,
"atr_expansion_pct": -13.6,
"di_plus": 10.3,
"di_minus": 30.5,
"high_52w": 90.17,
"low_52w": 49,
"structure": {
"ema8": 74.80454451921044,
"ema21": 77.34458691411352,
"ema50": 77.95848997202867,
"ema200": 71.36599417476461,
"ema10": 75.3305518170265,
"ema20": 77.22197369652628,
"ema10_slope_pct": -3.33,
"ema20_slope_pct": -2.66,
"trend_dir": "down",
"checks": {
"price_above_all": false,
"ema_stacked": false,
"ema21_rising": false,
"ema50_rising": false,
"adx_over_30": false,
"higher_highs_lows": false,
"lower_highs_lows": true,
"near_21ema": false
},
"dist_21ema_pct": -6.3,
"_no_bars": false,
"macd": {
"macd": -1.988,
"signal": -1.306,
"histogram": -0.682
},
"bollinger": {
"mid": 78.15,
"upper": 84.8,
"lower": 71.49,
"width_pct": 17.03
},
"crossover": {
"fresh_cross": null,
"pre_compressed": null,
"held_above_21": null,
"candles_since": null,
"intraday_support": false
},
"momentum": {
"roc10": -7.9,
"ret_3d": -3.1,
"ret_5d": -3.94,
"roc10_accel": 1.15,
"checks": {
"roc_over_5": false,
"rsi_in_band": false,
"macd_expanding": false,
"top_quartile_3d": false,
"no_big_down": true,
"near_high": false
},
"volume": {
"rvol": 0.88,
"checks": {
"rvol_over_2": false,
"up_vol_beats_down": false,
"obv_new_high": false,
"surge_day": false,
"pullback_declining_vol": false,
"last_up_beats_down": true
}
}
},
"relative_strength": {
"sector": "Healthcare",
"sector_etf": "XLV",
"sector_etf_ret10d": -4.54,
"checks": {
"beats_spy_all": false,
"beats_sector_10d": false,
"rs_line_at_high": false,
"sector_top3": true
}
},
"commodity": {},
"universe": {
"checks": {
"price_over_20": true,
"mcap_2b_to_200b": true,
"dollar_vol_over_10m": true,
"common_stock": true,
"no_earnings_7d": true
},
"avg_dollar_vol": 215812701.96899998
},
"options": {
"checks": {
"call_vol_2x": false,
"ivr_under_40": true,
"iv_contracting": false,
"oi_calls_above_price": true
},
"vals": {
"call_vol_mult": 0.9,
"iv_rank": 6.0
}
}
}
}
Data:
{
"prior_day": {
"high": 74.11,
"low": 71.98,
"close": 72.44,
"date": "2026-09-11"
},
"woodie_pivots": {
"PP": 72.74,
"R1": 73.5,
"S1": 71.38,
"R2": 74.87,
"S2": 70.62
},
"swing": {
"high_20d": 85.65,
"low_20d": 71.98,
"high_60d": 93.42,
"low_60d": 65.59
},
"orb": {
"high": 74.11,
"low": 72.59,
"date": "2026-09-11"
},
"vwap": 72.48,
"volume_profile": {
"poc": 76.61,
"vah": 80.46,
"val": 72.11,
"sessions": 20
},
"intraday": {
"h1_trend": "down",
"h1_last": 72.64,
"h1_ema9": 72.89,
"h1_ema21": 73.59,
"m15_trend": "down",
"m15_last": 72.14,
"m15_ema9": 72.46,
"m15_ema21": 72.57,
"rvol_intraday": 1.12,
"as_of_et": "2026-09-11 15:55"
},
"premarket": {
"date": "2026-09-11",
"high": 73.56,
"low": 73.56,
"last": 73.56,
"volume": 100,
"gap_pct": 1.46,
"path": "09:15 73.56",
"bars": 1,
"last_bar_et": "09:15"
},
"recent_daily": [
{
"d": "2026-08-07",
"o": 83.72,
"h": 85.03,
"l": 82.24,
"c": 84.48,
"v": 2148201.886539
},
{
"d": "2026-08-10",
"o": 83.45,
"h": 86,
"l": 83.45,
"c": 84.67,
"v": 2942576.090069
},
{
"d": "2026-08-11",
"o": 87.02,
"h": 89.49,
"l": 83.35,
"c": 83.7,
"v": 3082130.018582
},
{
"d": "2026-08-12",
"o": 83.47,
"h": 84.99,
"l": 82.82,
"c": 83.84,
"v": 2793619.945021
},
{
"d": "2026-08-13",
"o": 84.77,
"h": 84.77,
"l": 80.78,
"c": 81.21,
"v": 1279657.839063
},
{
"d": "2026-08-14",
"o": 80.14,
"h": 80.56,
"l": 78.6,
"c": 79.86,
"v": 3094032.601885
},
{
"d": "2026-08-17",
"o": 79.15,
"h": 80.42,
"l": 78.125,
"c": 79.89,
"v": 2795715.834355
},
{
"d": "2026-08-18",
"o": 80.54,
"h": 83.95,
"l": 80.1,
"c": 82.98,
"v": 2718343.392455
},
{
"d": "2026-08-19",
"o": 84.22,
"h": 85.65,
"l": 83.25,
"c": 83.95,
"v": 3285282.245704
},
{
"d": "2026-08-20",
"o": 83.51,
"h": 84.3646,
"l": 82.63,
"c": 82.94,
"v": 2030559.043597
},
{
"d": "2026-08-21",
"o": 82.89,
"h": 83.3667,
"l": 81.36,
"c": 81.5,
"v": 1743869.316956
},
{
"d": "2026-08-24",
"o": 80.98,
"h": 81.68,
"l": 80.16,
"c": 81.07,
"v": 1113409.163897
},
{
"d": "2026-08-25",
"o": 81.89,
"h": 82.5,
"l": 80.2,
"c": 80.4,
"v": 1469328.293761
},
{
"d": "2026-08-26",
"o": 79.75,
"h": 80.76,
"l": 79.33,
"c": 79.37,
"v": 1705025.239704
},
{
"d": "2026-08-27",
"o": 79.25,
"h": 79.725,
"l": 78.34,
"c": 78.68,
"v": 1033772.62146
},
{
"d": "2026-08-28",
"o": 79.99,
"h": 80.55,
"l": 76.34,
"c": 76.6,
"v": 1922281.856669
},
{
"d": "2026-08-31",
"o": 76.2,
"h": 77.235,
"l": 75.02,
"c": 76.59,
"v": 2063610.514849
},
{
"d": "2026-09-01",
"o": 76.61,
"h": 77.451,
"l": 76.22,
"c": 76.57,
"v": 1448465.714929
},
{
"d": "2026-09-02",
"o": 76.6,
"h": 78.2499,
"l": 75.955,
"c": 76.5,
"v": 1620739.402114
},
{
"d": "2026-09-03",
"o": 76.43,
"h": 76.64,
"l": 75.2,
"c": 75.41,
"v": 1098134.984929
},
{
"d": "2026-09-04",
"o": 74.98,
"h": 75.365,
"l": 74.11,
"c": 74.84,
"v": 1539365.280779
},
{
"d": "2026-09-08",
"o": 73.6,
"h": 76.34,
"l": 73.26,
"c": 74.76,
"v": 2094552.444234
},
{
"d": "2026-09-09",
"o": 73.63,
"h": 76.81,
"l": 73.465,
"c": 76.08,
"v": 2307058.79069
},
{
"d": "2026-09-10",
"o": 75.27,
"h": 75.5,
"l": 72.12,
"c": 72.5,
"v": 3064581.877334
},
{
"d": "2026-09-11",
"o": 73.225,
"h": 74.105,
"l": 71.98,
"c": 72.44,
"v": 1748654.310163
}
]
}
Data:
{
"sector": "Healthcare",
"etf": "XLV",
"etf_trend": "mixed",
"etf_r5d": -4.22,
"etf_rvol": 1.0,
"rs_5d": -1.01,
"leading": false
}
Data:
{
"estimates": [
{
"symbol": "BBIO",
"date": "2030-12-31",
"revenueLow": 4228166722,
"revenueHigh": 5621212485,
"revenueAvg": 4716010000,
"ebitdaLow": 2707770284,
"ebitdaHigh": 3699388079,
"ebitdaAvg": 3055034000,
"ebitLow": 2312950086,
"ebitHigh": 3304567881,
"ebitAvg": 2660213802,
"netIncomeLow": 1765694308,
"netIncomeHigh": 2549072366,
"netIncomeAvg": 2040032644,
"sgaExpenseLow": 19615415272,
"sgaExpenseHigh": 26078067511,
"sgaExpenseAvg": 21878629832,
"epsAvg": 10.343,
"epsHigh": 12.92384,
"epsLow": 8.9521,
"numAnalystsRevenue": 14,
"numAnalystsEps": 11
},
{
"symbol": "BBIO",
"date": "2029-12-31",
"revenueLow": 3351815618,
"revenueHigh": 4456131710,
"revenueAvg": 3738546045,
"ebitdaLow": 2023961558,
"ebitdaHigh": 2764672642,
"ebitdaAvg": 2283356992,
"ebitLow": 1747423797,
"ebitHigh": 2488134881,
"ebitAvg": 2006819231,
"netIncomeLow": 1318928540,
"netIncomeHigh": 1904090296,
"netIncomeAvg": 1523850933,
"sgaExpenseLow": 15549825630,
"sgaExpenseHigh": 20672996063,
"sgaExpenseAvg": 17343954959,
"epsAvg": 7.72595,
"epsHigh": 9.65377,
"epsLow": 6.68699,
"numAnalystsRevenue": 14,
"numAnalystsEps": 7
},
{
"symbol": "BBIO",
"date": "2028-12-31",
"revenueLow": 2282236240,
"revenueHigh": 3610209954,
"revenueAvg": 2594774774,
"ebitdaLow": 394415363,
"ebitdaHigh": 2097093628,
"ebitdaAvg": 1187225697,
"ebitLow": 220756729,
"ebitHigh": 1923434994,
"ebitAvg": 1013567063,
"netIncomeLow": 112861556,
"netIncomeHigh": 1457977386,
"netIncomeAvg": 739181720,
"sgaExpenseLow": 10587806617,
"sgaExpenseHigh": 16748575002,
"sgaExpenseAvg": 12037743087,
"epsAvg": 3.70131,
"epsHigh": 7.39197,
"epsLow": 0.57221,
"numAnalystsRevenue": 16,
"numAnalystsEps": 14
},
{
"symbol": "BBIO",
"date": "2027-12-31",
"revenueLow": 1490463023,
"revenueHigh": 1893290867,
"revenueAvg": 1681806249,
"ebitdaLow": 104333269,
"ebitdaHigh": 291091139,
"ebitdaAvg": 185492414,
"ebitLow": 6647690,
"ebitHigh": 193405560,
"ebitAvg": 87806835,
"netIncomeLow": -71246310,
"netIncomeHigh": 91254133,
"netIncomeAvg": 7831140,
"sgaExpenseLow": 6914592793,
"sgaExpenseHigh": 8783401655,
"sgaExpenseAvg": 7802277003,
"epsAvg": 0.089068,
"epsHigh": 0.46266,
"epsLow": -0.36122,
"numAnalystsRevenue": 14,
"numAnalystsEps": 12
}
],
"price_target": {
"symbol": "BBIO",
"targetHigh": 130,
"targetLow": 97,
"targetConsensus": 109.08,
"targetMedian": 108.5
},
"ratings": {
"symbol": "BBIO",
"rating": "C",
"overallScore": 2,
"discountedCashFlowScore": 1,
"returnOnEquityScore": 5,
"returnOnAssetsScore": 1,
"debtToEquityScore": 1,
"priceToEarningsScore": 1,
"priceToBookScore": 1
},
"grades": [
{
"symbol": "BBIO",
"date": "2026-09-10",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "BBIO",
"date": "2026-09-02",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "BBIO",
"date": "2026-09-01",
"gradingCompany": "Mizuho",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "BBIO",
"date": "2026-08-12",
"gradingCompany": "Truist Securities",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "BBIO",
"date": "2026-08-12",
"gradingCompany": "Canaccord Genuity",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "BBIO",
"date": "2026-08-12",
"gradingCompany": "JP Morgan",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "BBIO",
"date": "2026-08-11",
"gradingCompany": "Wells Fargo",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "BBIO",
"date": "2026-08-11",
"gradingCompany": "Piper Sandler",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "BBIO",
"date": "2026-08-11",
"gradingCompany": "Morgan Stanley",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "BBIO",
"date": "2026-08-11",
"gradingCompany": "B of A Securities",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "BBIO",
"date": "2026-08-11",
"gradingCompany": "TD Cowen",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "BBIO",
"date": "2026-07-16",
"gradingCompany": "Citigroup",
"previousGrade": "Neutral",
"newGrade": "Neutral",
"action": "maintain"
},
{
"symbol": "BBIO",
"date": "2026-07-13",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "BBIO",
"date": "2026-06-16",
"gradingCompany": "Mizuho",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "BBIO",
"date": "2026-05-28",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "BBIO",
"date": "2026-05-28",
"gradingCompany": "Morgan Stanley",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "BBIO",
"date": "2026-05-26",
"gradingCompany": "Raymond James",
"previousGrade": "Outperform",
"newGrade": "Market Perform",
"action": "downgrade"
},
{
"symbol": "BBIO",
"date": "2026-05-11",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "BBIO",
"date": "2026-05-08",
"gradingCompany": "Evercore ISI Group",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "BBIO",
"date": "2026-04-29",
"gradingCompany": "Truist Securities",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "BBIO",
"date": "2026-04-29",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "BBIO",
"date": "2026-04-28",
"gradingCompany": "Mizuho",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "BBIO",
"date": "2026-04-27",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "BBIO",
"date": "2026-03-18",
"gradingCompany": "Mizuho",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "BBIO",
"date": "2026-03-10",
"gradingCompany": "JP Morgan",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "BBIO",
"date": "2026-02-25",
"gradingCompany": "Oppenheimer",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "BBIO",
"date": "2026-02-25",
"gradingCompany": "Morgan Stanley",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "BBIO",
"date": "2026-02-25",
"gradingCompany": "Truist Securities",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "BBIO",
"date": "2026-02-25",
"gradingCompany": "Evercore ISI Group",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "BBIO",
"date": "2026-02-17",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "BBIO",
"date": "2026-02-13",
"gradingCompany": "Wells Fargo",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "BBIO",
"date": "2026-02-13",
"gradingCompany": "Oppenheimer",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "BBIO",
"date": "2026-01-20",
"gradingCompany": "Wells Fargo",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "BBIO",
"date": "2026-01-08",
"gradingCompany": "Truist Securities",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "BBIO",
"date": "2025-12-15",
"gradingCompany": "Leerink Partners",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "BBIO",
"date": "2025-11-11",
"gradingCompany": "Wells Fargo",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "BBIO",
"date": "2025-11-07",
"gradingCompany": "JP Morgan",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "BBIO",
"date": "2025-11-03",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "BBIO",
"date": "2025-10-31",
"gradingCompany": "Goldman Sachs",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "BBIO",
"date": "2025-10-30",
"gradingCompany": "Raymond James",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "BBIO",
"date": "2025-10-30",
"gradingCompany": "Cantor Fitzgerald",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "BBIO",
"date": "2025-10-30",
"gradingCompany": "Piper Sandler",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "BBIO",
"date": "2025-10-30",
"gradingCompany": "Truist Securities",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "BBIO",
"date": "2025-10-30",
"gradingCompany": "TD Cowen",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "BBIO",
"date": "2025-10-29",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "BBIO",
"date": "2025-10-27",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "BBIO",
"date": "2025-10-21",
"gradingCompany": "Raymond James",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "BBIO",
"date": "2025-09-15",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "BBIO",
"date": "2025-09-12",
"gradingCompany": "UBS",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
}
]
}
Data:
[
{
"title": "BridgeBio Pharma, Inc. (BBIO) Presents at 12th Annual Cantor Fitzgerald Global Healthcare Conference Transcript",
"url": "https://seekingalpha.com/article/4945073-bridgebio-pharma-inc-bbio-presents-at-12th-annual-cantor-fitzgerald-global-healthcare",
"source": "Seeking Alpha",
"date": "2026-09-10 12:17:10",
"summary": "BridgeBio Pharma, Inc. (BBIO) Presents at 12th Annual Cantor Fitzgerald Global Healthcare Conference Transcript",
"image": "https://images.financialmodelingprep.com/news/bridgebio-pharma-inc-bbio-presents-at-12th-annual-cantor-20260910.jpg"
},
{
"title": "BridgeBio Pharma: Attruby Peak Sales Set To Rise",
"url": "https://seekingalpha.com/article/4944921-bridgebio-pharma-stock-attruby-peak-sales-set-to-rise",
"source": "Seeking Alpha",
"date": "2026-09-10 08:25:52",
"summary": "BridgeBio pharma has delivered multiple clinical and commercial successes, yet shares have repeatedly sold off after positive catalysts. Infigratinib's dwarfism trial outperformed the market leader, and Attruby continues to beat sales estimates, with management now guiding higher",
"image": "https://images.financialmodelingprep.com/news/bridgebio-pharma-attruby-peak-sales-set-to-rise-20260910.jpg"
},
{
"title": "BridgeBio at Wells Fargo conference: growth plan centers on 2027 launches By Investing.com",
"url": "https://www.investing.com/news/transcripts/bridgebio-at-wells-fargo-conference-growth-plan-centers-on-2027-launches-93CH-4894364",
"source": "Investing.com",
"date": "2026-09-09T19:01:48Z",
"summary": "Wednesday, 09 September 2026 -- At the Wells Fargo 21st Annual Healthcare Conference, BridgeBio (BBIO) outlined a strategy built on one fast-growing commercial drug and three major launches expected in 2027. Management said the company has strong revenue momentum in acoramidis, b",
"image": "https://content-media.investing.com/news/moved_LYNXMPEM4416N_1200_L.jpg"
},
{
"title": "BridgeBio Pharma, Inc. (BBIO) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript",
"url": "https://seekingalpha.com/article/4944604-bridgebio-pharma-inc-bbio-presents-at-wells-fargo-21st-annual-healthcare-conference",
"source": "Seeking Alpha",
"date": "2026-09-09 18:47:21",
"summary": "BridgeBio Pharma, Inc. (BBIO) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript",
"image": "https://images.financialmodelingprep.com/news/bridgebio-pharma-inc-bbio-presents-at-wells-fargo-21st-20260909.jpg"
},
{
"title": "BridgeBio Pharma (BBIO) Down 10.7% Since Last Earnings Report: Can It Rebound?",
"url": "https://www.zacks.com/stock/news/2987140/bridgebio-pharma-bbio-down-10-7-since-last-earnings-report-can-it-rebound?cid=CS-STOCKNEWSAPI-FT-realtime_blog-2987140",
"source": "Zacks Investment Research",
"date": "2026-09-09 12:31:10",
"summary": "BridgeBio Pharma (BBIO) reported earnings 30 days ago. What's next for the stock?",
"image": "https://images.financialmodelingprep.com/news/bridgebio-pharma-bbio-down-107-since-last-earnings-report-20260909.jpg"
},
{
"title": "Oral Infigratinib Shows Meaningful Benefits Beyond Growth Within 52 Weeks in Children with Achondroplasia in the Phase 3 PROPEL 3 Trial",
"url": "https://www.globenewswire.com/news-release/2026/09/09/3358343/0/en/oral-infigratinib-shows-meaningful-benefits-beyond-growth-within-52-weeks-in-children-with-achondroplasia-in-the-phase-3-propel-3-trial.html",
"source": "GlobeNewsWire",
"date": "2026-09-09 04:00:00",
"summary": "- Treatment with oral infigratinib for 52 weeks in PROPEL 3 resulted in favorable trends against placebo in clinically meaningful exploratory endpoints including sleep apnea and otitis media events",
"image": "https://images.financialmodelingprep.com/news/oral-infigratinib-shows-meaningful-benefits-beyond-growth-within-52-20260909.jpg"
},
{
"title": "Frazier Life Sciences Management L.P. Sells 1,900,000 Shares of BridgeBio Pharma, Inc. $BBIO",
"url": "https://www.defenseworld.net/2026/09/07/frazier-life-sciences-management-l-p-sells-1900000-shares-of-bridgebio-pharma-inc-bbio.html",
"source": "Defense World",
"date": "2026-09-07 04:20:14",
"summary": "Frazier Life Sciences Management L.P. decreased its stake in shares of BridgeBio Pharma, Inc. (NASDAQ: BBIO) by 55.1% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,548,139 shares of t",
"image": "https://images.financialmodelingprep.com/news/frazier-life-sciences-management-lp-sells-1900000-shares-of-20260907.png"
},
{
"title": "BridgeBio (BBIO) Reported Signs of Cardiac Reversal With Acoramidis. How Much Weight Should Investors Give a Completer Analysis?",
"url": "https://finance.yahoo.com/healthcare/articles/bridgebio-bbio-reported-signs-cardiac-161850550.html",
"source": "Yahoo! Finance",
"date": "2026-09-04T16:18:50Z",
"summary": "BridgeBio Pharma, Inc. (NASDAQ:BBIO) is asking investors to look beyond disease stabilization in transthyretin amyloid cardiomyopathy, or ATTR-CM. New cardiac magnetic resonance imaging data from the Phase 3 ATTRibute-CM study and its open-label extension suggested that some acor",
"image": "https://s.yimg.com/lo/mysterio/api/fcdf90610903c63d49284f1fe88358061e418f5a0ae09e9d4cca0d3e4f6dfcb9/lightyear_networkapi/resizefill_w1200%3Bquality_80%3Bformat_webp/https%3A%2F%2Fmedia.zenfs.com%2Fen%2Finsidermonkey.com%2F94d929893d7a95dd82280ff6392256a0.jpg"
},
{
"title": "How BioMarin Turned a Competitive Threat Into a Royalty-Bearing Asset",
"url": "https://www.zacks.com/stock/news/2984720/how-biomarin-turned-a-competitive-threat-into-a-royalty-bearing-asset?cid=CS-ZC-FT-analyst_blog|quick_take-2984720",
"source": "Zacks Investment Research",
"date": "2026-09-03T16:28:00Z",
"summary": "BioMarin settled a patent dispute with Ascendis Pharma over the achondroplasia drug Yuviwel, converting a competitive threat into a royalty stream. Under the agreement, BioMarin will receive 20% royalties on U.S. Yuviwel sales and 18% in the EU, Brazil, and South Korea through Ma",
"image": "https://staticx-tuner.zacks.com/images/articles/main/21/594.jpg"
},
{
"title": "BridgeBio to Present New Data on the Impact of Oral Infigratinib on Medical Complications in Achondroplasia at the Annual ESPE Meeting 2026",
"url": "https://www.globenewswire.com/news-release/2026/09/02/3355025/0/en/bridgebio-to-present-new-data-on-the-impact-of-oral-infigratinib-on-medical-complications-in-achondroplasia-at-the-annual-espe-meeting-2026.html",
"source": "GlobeNewsWire",
"date": "2026-09-02 07:30:00",
"summary": "PALO ALTO, Calif., Sept. 02, 2026 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (\u201cBridgeBio\u201d or the \u201cCompany\u201d), a commercial-stage, multi-product biopharmaceutical company focused on developing medicines for genetic conditions, announced today that one late-breaking o",
"image": "https://images.financialmodelingprep.com/news/bridgebio-to-present-new-data-on-the-impact-of-20260902.jpg"
},
{
"title": "Trump's MFN Push Goes Beyond Big Pharma, Adds 9 Mid-Sized Drugmakers",
"url": "https://www.zacks.com/stock/news/2983369/trump-s-mfn-push-goes-beyond-big-pharma-adds-9-mid-sized-drugmakers?cid=CS-STOCKNEWSAPI-FT-analyst_blog|industry_focus-2983369",
"source": "Zacks Investment Research",
"date": "2026-09-01 13:35:52",
"summary": "Trump's MFN push expands to nine mid-sized drugmakers, bringing 26 companies under agreements covering 89% of the branded drug market.",
"image": "https://images.financialmodelingprep.com/news/trumps-mfn-push-goes-beyond-big-pharma-adds-9-20260901.jpg"
},
{
"title": "4 Rare Disease Drugmakers With Strong Long-Term Growth Prospects",
"url": "https://www.zacks.com/stock/news/2983201/4-rare-disease-drugmakers-with-strong-long-term-growth-prospects?cid=CS-STOCKNEWSAPI-FT-analyst_blog|investment_ideas-2983201",
"source": "Zacks Investment Research",
"date": "2026-09-01 12:01:11",
"summary": "ALNY, BMRN, RARE and BBIO offer rare-disease growth potential through strong products, pipeline catalysts and high unmet medical needs.",
"image": "https://images.financialmodelingprep.com/news/4-rare-disease-drugmakers-with-strong-longterm-growth-prospects-20260901.jpg"
},
{
"title": "BridgeBio to Participate in September Investor Conferences",
"url": "https://www.globenewswire.com/news-release/2026/09/01/3354014/0/en/bridgebio-to-participate-in-september-investor-conferences.html",
"source": "GlobeNewsWire",
"date": "2026-09-01 07:30:00",
"summary": "PALO ALTO, Calif., Sept. 01, 2026 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (\u201cBridgeBio\u201d or the \u201cCompany\u201d), a commercial-stage, multi-product biopharmaceutical company focused on developing medicines for genetic conditions, today announced that members of its mana",
"image": "https://images.financialmodelingprep.com/news/bridgebio-to-participate-in-september-investor-conferences-20260901.jpg"
},
{
"title": "Stock Market News - Investing.com",
"url": "https://www.investing.com/news/stock-market-news/trump-announces-drug-pricing-deals-with-nine-pharmaceutical-firms-93CH-4883303",
"source": "Investing.com",
"date": "2026-08-31T21:15:19Z",
"summary": "Investing.com -- President Donald Trump announced drug pricing agreements with nine pharmaceutical companies on Monday as part of efforts to reduce healthcare costs for Americans.\n\nThe agreements were signed with Astellas (TYO:4503), BeOne Medicines (SHH:688235), CSL (ASX:CSL), B",
"image": "https://i-invdn-com.investing.com/redesign/images/seo/investing_300X300.png"
},
{
"title": "BridgeBio Announces Agreement with U.S. Government to Improve Affordability and Access to Critical Medicines for Americans",
"url": "https://www.globenewswire.com/news-release/2026/08/31/3353662/0/en/bridgebio-announces-agreement-with-u-s-government-to-improve-affordability-and-access-to-critical-medicines-for-americans.html",
"source": "GlobeNewswire Inc.",
"date": "2026-08-31T19:44:00Z",
"summary": "BridgeBio Pharma has entered into a voluntary agreement with the U.S. government to expand Medicaid access to its marketed medicine Attruby and lower drug costs for American patients. The agreement includes expanded state Medicaid access via the GENEROUS Model and maintains the c",
"image": "https://ml.globenewswire.com/Resource/Download/2074ba9b-0e5b-41fa-baac-553f1345bb75"
},
{
"title": "Mizuho raises BridgeBio Pharma stock price target to $110 on Attruby By Investing.com",
"url": "https://www.investing.com/news/analyst-ratings/mizuho-raises-bridgebio-pharma-stock-price-target-to-110-on-attruby-93CH-4883154",
"source": "Investing.com",
"date": "2026-08-31T18:46:51Z",
"summary": "Investing.com - Mizuho raised its price target on BridgeBio Pharma stock (NASDAQ:BBIO) to $110 from $96 while maintaining an Outperform rating. The stock currently trades at $76.07, suggesting significant upside potential to the analyst's target. With an analyst consensus rating ",
"image": "https://content-media.investing.com/news/moved_LYNXMPEM3T1AG_1200_L.jpg"
},
{
"title": "Acoramidis Demonstrates Reversal of Cardiac Structural Disease Progression and Functional Decline and Significantly Increases Days Alive and Free from Hospitalization in ATTR-CM",
"url": "https://www.globenewswire.com/news-release/2026/08/30/3352965/0/en/acoramidis-demonstrates-reversal-of-cardiac-structural-disease-progression-and-functional-decline-and-significantly-increases-days-alive-and-free-from-hospitalization-in-attr-cm.html",
"source": "GlobeNewsWire",
"date": "2026-08-30 10:00:00",
"summary": "- Acoramidis is the first therapy shown to potentially reverse cardiac structural disease progression and functional decline through 42 months based on CMR imaging, \u00a0with up to half of patients showing clinically meaningful improvement in cardiac function in the completer analysi",
"image": "https://images.financialmodelingprep.com/news/acoramidis-demonstrates-reversal-of-cardiac-structural-disease-progression-and-20260830.jpg"
},
{
"title": "BridgeBio doses first patient in acoramidis heart study By Investing.com",
"url": "https://www.investing.com/news/company-news/bridgebio-doses-first-patient-in-acoramidis-heart-study-93CH-4876979",
"source": "Investing.com",
"date": "2026-08-26T11:36:39Z",
"summary": "PALO ALTO, Calif. - BridgeBio Pharma Inc. (NASDAQ:BBIO) announced today that the first participant has been dosed in ASCEND-ATTR, a Phase 3b/4 study examining the long-term effects of acoramidis on cardiac structure, function, and amyloid burden in patients with transthyretin amy",
"image": "https://i-invdn-com.investing.com/redesign/images/seo/investing_300X300.png"
},
{
"title": "BridgeBio Announces First Participant Dosed in ASCEND-ATTR, a Phase 3b/4 Study Evaluating the Long-Term Effects of Acoramidis on Disease Regression in ATTR-CM",
"url": "https://www.globenewswire.com/news-release/2026/08/26/3351235/0/en/bridgebio-announces-first-participant-dosed-in-ascend-attr-a-phase-3b-4-study-evaluating-the-long-term-effects-of-acoramidis-on-disease-regression-in-attr-cm.html",
"source": "GlobeNewsWire",
"date": "2026-08-26 07:30:00",
"summary": "- The ASCEND-ATTR study builds on the Phase 3 ATTRibute-CM CMR substudy results previously shared here, which indicated treatment with acoramidis may improve cardiac structure and function with evidence of amyloid regression in a subset of patients",
"image": "https://images.financialmodelingprep.com/news/bridgebio-announces-first-participant-dosed-in-ascendattr-a-phase-20260826.jpg"
},
{
"title": "BridgeBio Q2 Sales Jump 120% as Attruby Drives Commercial Momentum",
"url": "https://www.zacks.com/stock/news/2979981/bridgebio-q2-sales-jump-120-as-attruby-drives-commercial-momentum?cid=CS-STOCKNEWSAPI-FT-analyst_blog_plus|zer_report_insights-2979981",
"source": "Zacks Investment Research",
"date": "2026-08-25 14:42:03",
"summary": "BBIO's Q2 sales jump 120% as Attruby drives growth, while higher spending widens the loss and raises the stakes for 2026.",
"image": "https://images.financialmodelingprep.com/news/bridgebio-q2-sales-jump-120-as-attruby-drives-commercial-20260825.jpg"
},
{
"title": "Why BBIO Rose 24% in Three Months and Whether the Rally Can Continue",
"url": "https://www.zacks.com/stock/news/2979977/why-bbio-rose-24-in-three-months-and-whether-the-rally-can-continue?cid=CS-STOCKNEWSAPI-FT-analyst_blog_plus|zer_report_insights-2979977",
"source": "Zacks Investment Research",
"date": "2026-08-25 14:36:09",
"summary": "BridgeBio's 24% three-month rally faces a higher bar as Attruby growth and pipeline catalysts compete with valuation and execution risks.",
"image": "https://images.financialmodelingprep.com/news/why-bbio-rose-24-in-three-months-and-whether-20260825.jpg"
},
{
"title": "BridgeBio (BBIO) Q2 2026 Earnings Call Transcript",
"url": "https://finance.yahoo.com/healthcare/articles/bridgebio-bbio-q2-2026-earnings-130929277.html",
"source": "Yahoo! Finance",
"date": "2026-08-19T13:09:29Z",
"summary": "Image source: The Motley Fool.\n\nDATE\n\nMonday, Aug. 10, 2026 at 4:30 p.m. ET\n\nCALL PARTICIPANTS\n\n* Senior Vice President, Strategic Finance-Chinmay Shukla\n\n* Chief Executive Officer-Neil Kumar\n\n* Chief Commercial Officer-Matthew Outten\n\n* President and Chief Financial Officer-Thom",
"image": "https://s.yimg.com/lo/mysterio/api/4DB848F3883357D440BBA497AB43FD51EBC98B573C3FC535F97A93E5867FE1B4/subgraphmysterio/resizefill_w1200_h1281;quality_80;format_webp/https:%2F%2Fmedia.zenfs.com%2Fen%2Fmotleyfool.com%2Fa726d4819c9ce56f8dbd126ba4eb20c8.png"
},
{
"title": "Why the Alnylam Sell-Off Looks Overdone -- and What Investors Are Missing",
"url": "https://finance.yahoo.com/healthcare/articles/why-alnylam-sell-off-looks-100100216.html",
"source": "Yahoo! Finance",
"date": "2026-08-16T10:01:00Z",
"summary": "Alnylam Pharmaceuticals (NASDAQ: ALNY) looks like an investor's nightmare at first glance. The drugmaker's shares have lost more than half their value over the past 12 months. The biotech stock is down more than 20% over the past four weeks.\n\nSome Alnylam shareholders could be so",
"image": "https://s.yimg.com/lo/mysterio/api/C9AA79674404F402F9238C107C3A0ABDC695986FBBDE5D3F8AD42E9B1D477B25/subgraphmysterio/resizefill_w1200_h800;quality_80;format_webp/https:%2F%2Fmedia.zenfs.com%2Fen%2Fmotleyfool.com%2F10af00c5fc696c84c6bce26e30a3a875.jpg"
},
{
"title": "BridgeBio Stock Has Soared 29% in Just 3 Months. Here's Why Wall Street Thinks It Could Go Even Higher.",
"url": "https://finance.yahoo.com/healthcare/articles/bridgebio-stock-soared-29-just-153500812.html",
"source": "Yahoo! Finance",
"date": "2026-08-14T15:35:00Z",
"summary": "One of the more high-flying stocks in the U.S. biotech sector these days is genetic-disease-focused BridgeBio Pharma (NASDAQ: BBIO). That's due almost entirely to the outperformance of its Attruby heart medication.\n\nIf the generally bullish analyst sentiment on the company is any",
"image": "https://s.yimg.com/lo/mysterio/api/D11AB3FB009C0C03A66424817A56F5D6467868C36F083C72B751C1CA990A6C93/subgraphmysterio/resizefill_w1200_h585;quality_80;format_webp/https:%2F%2Fmedia.zenfs.com%2Fen%2Fmotleyfool.com%2F364ec54b9435f7b676a166c4829a1999.jpg"
},
{
"title": "BridgeBio shares fall as KKR launches secondary offering By Investing.com",
"url": "https://www.investing.com/news/stock-market-news/bridgebio-shares-fall-as-kkr-launches-secondary-offering-93CH-4859434",
"source": "Investing.com",
"date": "2026-08-13T21:53:58Z",
"summary": "Investing.com -- BridgeBio Pharma Inc (NASDAQ:BBIO) shares declined 1.5% in after-hours trading Thursday following the announcement of a secondary public offering by selling stockholder KKR Genetic Disorder L.P.\n\nKKR plans to sell 5 million shares of BridgeBio common stock in the",
"image": "https://content-media.investing.com/news/fa8a2f803ea2ddf92359d55091dcde0a_L.jpg"
}
]
Data:
[
{
"symbol": "BBIO",
"date": "2026-10-28",
"epsActual": null,
"epsEstimated": -0.67,
"revenueActual": null,
"revenueEstimated": 270329300,
"lastUpdated": "2026-09-11"
},
{
"symbol": "BBIO",
"date": "2026-08-10",
"epsActual": -0.78,
"epsEstimated": -0.57558,
"revenueActual": 243676000,
"revenueEstimated": 220910100,
"lastUpdated": "2026-09-11"
},
{
"symbol": "BBIO",
"date": "2026-05-07",
"epsActual": -0.84,
"epsEstimated": -0.67877,
"revenueActual": 194515000,
"revenueEstimated": 178066400,
"lastUpdated": "2026-08-07"
},
{
"symbol": "BBIO",
"date": "2026-02-24",
"epsActual": -1,
"epsEstimated": -0.71343,
"revenueActual": 154178000,
"revenueEstimated": 146835500,
"lastUpdated": "2026-05-24"
},
{
"symbol": "BBIO",
"date": "2025-10-29",
"epsActual": -0.95,
"epsEstimated": -0.88,
"revenueActual": 120700000,
"revenueEstimated": 148152410,
"lastUpdated": "2026-01-29"
}
]
Data:
{
"borrow": [],
"short_interest": [
{
"symbol": "BBIO",
"file_date": "",
"error": "Symbol not found in FINRA biweekly file",
"days_to_cover": null
}
],
"ftd": {
"symbol": "BBIO",
"periods": [
{
"file_period": "202604b",
"settlement_date": "20260430",
"quantity_fails": 22615,
"price": 70.94
},
{
"file_period": "202606a",
"settlement_date": "20260605",
"quantity_fails": 7,
"price": 67.33
},
{
"file_period": "202606b",
"settlement_date": "20260630",
"quantity_fails": 1697839,
"price": 72.01
},
{
"file_period": "202607a",
"settlement_date": "20260708",
"quantity_fails": 7800,
"price": 77.91
},
{
"file_period": "202607b",
"settlement_date": "20260728",
"quantity_fails": 10,
"price": 84.12
},
{
"file_period": "202608a",
"settlement_date": "20260805",
"quantity_fails": 15279,
"price": 82.07
}
],
"trend": "falling",
"trend_description": "FTD quantity declining \u2014 shorts covering or delivery improving"
}
}
Data:
{
"insider": [
{
"symbol": "BBIO",
"filingDate": "2026-08-20",
"transactionDate": "2026-08-19",
"reportingCik": "0001742485",
"companyCik": "0001743881",
"transactionType": "S-Sale",
"securitiesOwned": 507586,
"reportingName": "Kumar Neil",
"typeOfOwner": "director, officer: Chief Executive Officer",
"acquisitionOrDisposition": "D",
"directOrIndirect": "I",
"formType": "4",
"securitiesTransacted": 8100,
"price": 83.8588,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/1743881/000147083126000848/0001470831-26-000848-index.htm"
},
{
"symbol": "BBIO",
"filingDate": "2026-08-20",
"transactionDate": "2026-08-19",
"reportingCik": "0001742485",
"companyCik": "0001743881",
"transactionType": "S-Sale",
"securitiesOwned": 505786,
"reportingName": "Kumar Neil",
"typeOfOwner": "director, officer: Chief Executive Officer",
"acquisitionOrDisposition": "D",
"directOrIndirect": "I",
"formType": "4",
"securitiesTransacted": 1800,
"price": 84.6867,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/1743881/000147083126000848/0001470831-26-000848-index.htm"
},
{
"symbol": "BBIO",
"filingDate": "2026-08-20",
"transactionDate": "2026-08-19",
"reportingCik": "0001742485",
"companyCik": "0001743881",
"transactionType": "S-Sale",
"securitiesOwned": 505686,
"reportingName": "Kumar Neil",
"typeOfOwner": "director, officer: Chief Executive Officer",
"acquisitionOrDisposition": "D",
"directOrIndirect": "I",
"formType": "4",
"securitiesTransacted": 100,
"price": 85.65,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/1743881/000147083126000848/0001470831-26-000848-index.htm"
},
{
"symbol": "BBIO",
"filingDate": "2026-08-20",
"transactionDate": "2026-08-18",
"reportingCik": "0001742485",
"companyCik": "0001743881",
"transactionType": "S-Sale",
"securitiesOwned": 276407,
"reportingName": "Kumar Neil",
"typeOfOwner": "director, officer: Chief Executive Officer",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 1900,
"price": 81.1494,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/1743881/000147083126000848/0001470831-26-000848-index.htm"
},
{
"symbol": "BBIO",
"filingDate": "2026-08-20",
"transactionDate": "2026-08-18",
"reportingCik": "0001742485",
"companyCik": "0001743881",
"transactionType": "S-Sale",
"securitiesOwned": 259128,
"reportingName": "Kumar Neil",
"typeOfOwner": "director, officer: Chief Executive Officer",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 17279,
"price": 82.2104,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/1743881/000147083126000848/0001470831-26-000848-index.htm"
},
{
"symbol": "BBIO",
"filingDate": "2026-08-20",
"transactionDate": "2026-08-18",
"reportingCik": "0001742485",
"companyCik": "0001743881",
"transactionType": "S-Sale",
"securitiesOwned": 244526,
"reportingName": "Kumar Neil",
"typeOfOwner": "director, officer: Chief Executive Officer",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 14602,
"price": 82.9922,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/1743881/000147083126000848/0001470831-26-000848-index.htm"
},
{
"symbol": "BBIO",
"filingDate": "2026-08-20",
"transactionDate": "2026-08-18",
"reportingCik": "0001742485",
"companyCik": "0001743881",
"transactionType": "S-Sale",
"securitiesOwned": 243327,
"reportingName": "Kumar Neil",
"typeOfOwner": "director, officer: Chief Executive Officer",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 1199,
"price": 83.7732,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/1743881/000147083126000848/0001470831-26-000848-index.htm"
},
{
"symbol": "BBIO",
"filingDate": "2026-08-18",
"transactionDate": "2026-08-16",
"reportingCik": "0002030813",
"companyCik": "0001743881",
"transactionType": "F-InKind",
"securitiesOwned": 336529,
"reportingName": "Trimarchi Thomas",
"typeOfOwner": "officer: President and CFO",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 22781,
"price": 79.86,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/1743881/000147083126000837/0001470831-26-000837-index.htm"
}
],
"congress": [
"status",
"endpoint",
"provided",
"message",
{
"symbol": "BBIO",
"senateID": "C001123",
"disclosureDate": "2026-06-09",
"transactionDate": "2026-05-10",
"firstName": "Gilbert Ray",
"lastName": "Cisneros",
"office": "Gilbert Cisneros",
"district": "CA31",
"owner": "",
"assetDescription": "BridgeBio Pharma, Inc. - Common Stock",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2026/20034713.pdf"
},
{
"symbol": "BBIO",
"senateID": "C001123",
"disclosureDate": "2026-05-11",
"transactionDate": "2026-04-28",
"firstName": "Gilbert Ray",
"lastName": "Cisneros",
"office": "Gilbert Cisneros",
"district": "CA31",
"owner": "",
"assetDescription": "BridgeBio Pharma, Inc. - Common Stock",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2026/20034500.pdf"
},
{
"symbol": "BBIO",
"senateID": "C001123",
"disclosureDate": "2026-04-08",
"transactionDate": "2026-03-02",
"firstName": "Gilbert Ray",
"lastName": "Cisneros",
"office": "Gilbert Cisneros",
"district": "CA31",
"owner": "",
"assetDescription": "BridgeBio Pharma, Inc. - Common Stock",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2026/20034285.pdf"
},
{
"symbol": "BBIO",
"senateID": "C001123",
"disclosureDate": "2026-04-08",
"transactionDate": "2026-03-18",
"firstName": "Gilbert Ray",
"lastName": "Cisneros",
"office": "Gilbert Cisneros",
"district": "CA31",
"owner": "",
"assetDescription": "BridgeBio Pharma, Inc. - Common Stock",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2026/20034285.pdf"
},
{
"symbol": "BBIO",
"senateID": "C001123",
"disclosureDate": "2026-04-08",
"transactionDate": "2026-03-17",
"firstName": "Gilbert Ray",
"lastName": "Cisneros",
"office": "Gilbert Cisneros",
"district": "CA31",
"owner": "",
"assetDescription": "BridgeBio Pharma, Inc. - Common Stock",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2026/20034285.pdf"
},
{
"symbol": "BBIO",
"senateID": "C001123",
"disclosureDate": "2025-10-10",
"transactionDate": "2025-09-21",
"firstName": "Gilbert Ray",
"lastName": "Cisneros",
"office": "Gilbert Cisneros",
"district": "CA31",
"owner": "",
"assetDescription": "BridgeBio Pharma, Inc. - Common Stock",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2025/20032248.pdf"
},
{
"symbol": "BBIO",
"senateID": "C001123",
"disclosureDate": "2025-09-12",
"transactionDate": "2025-08-07",
"firstName": "Gilbert Ray",
"lastName": "Cisneros",
"office": "Gilbert Cisneros",
"district": "CA31",
"owner": "",
"assetDescription": "BridgeBio Pharma, Inc. - Common Stock",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2025/20031022.pdf"
}
],
"dark_pool": [
{
"ticker": "BBIO",
"executed_at": "2026-09-11T20:00:31.545000Z",
"size": 10571.0,
"price": 72.44,
"premium": 765763.24,
"volume": 10571.0,
"trade_code": " "
},
{
"ticker": "BBIO",
"executed_at": "2026-09-11T20:00:01.648000Z",
"size": 3494.0,
"price": 72.44,
"premium": 253105.36,
"volume": 3494.0,
"trade_code": "6"
},
{
"ticker": "BBIO",
"executed_at": "2026-09-11T20:00:01.648000Z",
"size": 3494.0,
"price": 72.44,
"premium": 253105.36,
"volume": 3494.0,
"trade_code": "6"
},
{
"ticker": "BBIO",
"executed_at": "2026-09-11T20:00:30.868000Z",
"size": 2245.0,
"price": 72.44,
"premium": 162627.8,
"volume": 2245.0,
"trade_code": " "
},
{
"ticker": "BBIO",
"executed_at": "2026-09-11T20:00:30.848000Z",
"size": 2112.0,
"price": 72.44,
"premium": 152993.28,
"volume": 2112.0,
"trade_code": " "
},
{
"ticker": "BBIO",
"executed_at": "2026-09-11T20:00:01.648000Z",
"size": 1500.0,
"price": 72.44,
"premium": 108660.0,
"volume": 1500.0,
"trade_code": "6"
},
{
"ticker": "BBIO",
"executed_at": "2026-09-11T20:00:03.264000Z",
"size": 1445.0,
"price": 72.44,
"premium": 104675.8,
"volume": 1445.0,
"trade_code": " "
},
{
"ticker": "BBIO",
"executed_at": "2026-09-11T20:00:32.352000Z",
"size": 1300.0,
"price": 72.44,
"premium": 94172.0,
"volume": 1300.0,
"trade_code": " "
}
],
"ats": {
"symbol": "BBIO",
"date": "20260910",
"ats_volume": 0,
"total_volume": 1377918,
"ats_ratio": 0.0,
"ats_pct": 0.0,
"signal": "Low",
"history": [
{
"date": "20260910",
"ats_ratio": 0.0
},
{
"date": "20260909",
"ats_ratio": 0.0
},
{
"date": "20260908",
"ats_ratio": 0.0
},
{
"date": "20260904",
"ats_ratio": 0.0
},
{
"date": "20260903",
"ats_ratio": 0.0
}
]
},
"polygon_dp": {
"ticker": "BBIO",
"days": [
{
"date": "2026-09-11",
"close": 72.44,
"vwap": 72.48,
"volume": 1748654,
"vwap_discount_pct": 0.05
},
{
"date": "2026-09-10",
"close": 72.5,
"vwap": 72.99,
"volume": 3064581,
"vwap_discount_pct": 0.67
},
{
"date": "2026-09-09",
"close": 76.08,
"vwap": 75.74,
"volume": 2307058,
"vwap_discount_pct": -0.44
},
{
"date": "2026-09-08",
"close": 74.76,
"vwap": 74.65,
"volume": 2094552,
"vwap_discount_pct": -0.15
},
{
"date": "2026-09-04",
"close": 74.84,
"vwap": 74.54,
"volume": 1539365,
"vwap_discount_pct": -0.4
}
],
"avg_vwap_discount_pct": -0.05,
"signal": "Neutral"
},
"options_flow": [
{
"underlying_price": "72.415",
"underlying_symbol": "BBIO",
"size": 36,
"expiry": "2026-09-18",
"volume": 133,
"nbbo_ask": "3.40",
"open_interest": 483,
"executed_at": "2026-09-11T19:40:33.977000Z",
"option_type": "call",
"nbbo_bid": "2.80",
"option_chain_id": "BBIO260918C00070000",
"price": "3.20",
"sector": "Healthcare",
"strike": "70",
"implied_volatility": "0.4290699987680656",
"premium": "11520.00",
"delta": "0.730112649454791"
},
{
"underlying_price": "73.04",
"underlying_symbol": "BBIO",
"size": 5,
"expiry": "2028-01-21",
"volume": 27,
"nbbo_ask": "22.40",
"open_interest": 65,
"executed_at": "2026-09-11T13:53:59.240000Z",
"option_type": "call",
"nbbo_bid": "18.60",
"option_chain_id": "BBIO280121C00070000",
"price": "20.18",
"sector": "Healthcare",
"strike": "70",
"implied_volatility": "0.515231768680639",
"premium": "10090.00",
"delta": "0.680683953674484"
},
{
"underlying_price": "73.04",
"underlying_symbol": "BBIO",
"size": 5,
"expiry": "2028-01-21",
"volume": 22,
"nbbo_ask": "22.40",
"open_interest": 65,
"executed_at": "2026-09-11T13:53:59.240000Z",
"option_type": "call",
"nbbo_bid": "18.60",
"option_chain_id": "BBIO280121C00070000",
"price": "20.18",
"sector": "Healthcare",
"strike": "70",
"implied_volatility": "0.515231768680639",
"premium": "10090.00",
"delta": "0.680683953674484"
},
{
"underlying_price": "73.03",
"underlying_symbol": "BBIO",
"size": 5,
"expiry": "2028-01-21",
"volume": 36,
"nbbo_ask": "22.40",
"open_interest": 65,
"executed_at": "2026-09-11T13:55:45.557000Z",
"option_type": "call",
"nbbo_bid": "18.60",
"option_chain_id": "BBIO280121C00070000",
"price": "20.11",
"sector": "Healthcare",
"strike": "70",
"implied_volatility": "0.513156768678958",
"premium": "10055.00",
"delta": "0.680413816534908"
}
],
"net_premium": {
"ticker": "BBIO",
"net_call_premium": "-187403.00",
"net_put_premium": "-23017.00",
"call_premium": "350273.00",
"put_premium": "44038.00",
"bullish_premium": "104705.00",
"bearish_premium": "269091.00",
"put_call_ratio": "0.27272727272727272727",
"iv_rank": "6.3112",
"implied_move_perc": "0.085000",
"gex_ratio": "0.70792614700834665945",
"gex_net_change": "3862.0578",
"gex_call": "36752.9431",
"gex_put": "-26018.3694",
"gex_net": 10734.5737,
"gex_call_delta": "998982.2199",
"gex_put_delta": "-352523.6378",
"gex_date": "2026-09-11"
},
"hot_chains": [
{
"underlying_symbol": "BBIO",
"expires": "2026-09-18",
"open_interest": 767,
"option_type": "call",
"delta": 0.508848937268559,
"ask_volume": 123,
"last_price": "1.70",
"implied_volatility": "0.4203960742051185",
"gamma": 0.0885929029149456,
"avg_price": "1.7865053763440860215053763440",
"bid_volume": 63,
"nbbo_ask": "3.50",
"strike": "72.5",
"option_symbol": "BBIO260918C00072500",
"total_premium": "33229.00",
"iv": 0.448635576407759,
"volume": 186,
"nbbo_bid": "1.70"
},
{
"underlying_symbol": "BBIO",
"expires": "2026-09-18",
"open_interest": 483,
"option_type": "call",
"delta": 0.695666997308964,
"ask_volume": 19,
"last_price": "3.00",
"implied_volatility": "0.4366364274345397",
"gamma": 0.0665097825185541,
"avg_price": "3.3095238095238095238095238093",
"bid_volume": 92,
"nbbo_ask": "3.20",
"strike": "70",
"option_symbol": "BBIO260918C00070000",
"total_premium": "48650.00",
"iv": 0.524318142692558,
"volume": 147,
"nbbo_bid": "2.30"
},
{
"underlying_symbol": "BBIO",
"expires": "2027-01-15",
"open_interest": 22,
"option_type": "put",
"delta": -0.1997842703396874,
"ask_volume": 0,
"last_price": "2.75",
"implied_volatility": "0.494599400279448",
"gamma": 0.0145164441329391,
"avg_price": "2.7363636363636363636363636365",
"bid_volume": 110,
"nbbo_ask": "3.00",
"strike": "60",
"option_symbol": "BBIO270115P00060000",
"total_premium": "30100.00",
"iv": 0.452634176755921,
"volume": 110,
"nbbo_bid": "2.65"
},
{
"underlying_symbol": "BBIO",
"expires": "2028-01-21",
"open_interest": 65,
"option_type": "call",
"delta": 0.64818771171427,
"ask_volume": 15,
"last_price": "20.30",
"implied_volatility": "0.532588541461398",
"gamma": 0.00781315788464561,
"avg_price": "20.227980769230769230769230770",
"bid_volume": 88,
"nbbo_ask": "20.30",
"strike": "70",
"option_symbol": "BBIO280121C00070000",
"total_premium": "210371.00",
"iv": 0.561704102468433,
"volume": 104,
"nbbo_bid": "18.70"
},
{
"underlying_symbol": "BBIO",
"expires": "2026-10-16",
"open_interest": 207,
"option_type": "call",
"delta": 0.330846678053663,
"ask_volume": 12,
"last_price": "1.90",
"implied_volatility": "0.401824181842361",
"gamma": 0.0375174499550354,
"avg_price": "1.9952380952380952380952380952",
"bid_volume": 8,
"nbbo_ask": "3.00",
"strike": "77.5",
"option_symbol": "BBIO261016C00077500",
"total_premium": "4190.00",
"iv": 0.430636701398661,
"volume": 21,
"nbbo_bid": "1.90"
},
{
"underlying_symbol": "BBIO",
"expires": "2026-09-18",
"open_interest": 189,
"option_type": "call",
"delta": 0.0312177078349909,
"ask_volume": 0,
"last_price": "0.05",
"implied_volatility": "0.571979226652461",
"gamma": 0.01158311423452298,
"avg_price": "0.0500000000000000000000000000",
"bid_volume": 20,
"nbbo_ask": "0.50",
"strike": "85",
"option_symbol": "BBIO260918C00085000",
"total_premium": "100.00",
"iv": 0.604995016437405,
"volume": 20,
"nbbo_bid": "0.00"
},
{
"underlying_symbol": "BBIO",
"expires": "2028-01-21",
"open_interest": 53,
"option_type": "call",
"delta": 0.565998773725371,
"ask_volume": 1,
"last_price": "15.84",
"implied_volatility": "0.50846831236893",
"gamma": 0.00846909526650952,
"avg_price": "15.906315789473684210526315789",
"bid_volume": 17,
"nbbo_ask": "17.80",
"strike": "80",
"option_symbol": "BBIO280121C00080000",
"total_premium": "30222.00",
"iv": 0.549448186804122,
"volume": 19,
"nbbo_bid": "14.20"
},
{
"underlying_symbol": "BBIO",
"expires": "2026-11-20",
"open_interest": 184,
"option_type": "call",
"delta": 0.227871178008385,
"ask_volume": 0,
"last_price": "2.00",
"implied_volatility": "0.45263448077555",
"gamma": 0.02195930579284588,
"avg_price": "2.0050000000000000000000000000",
"bid_volume": 9,
"nbbo_ask": "2.20",
"strike": "85",
"option_symbol": "BBIO261120C00085000",
"total_premium": "2005.00",
"iv": 0.433365799870742,
"volume": 10,
"nbbo_bid": "1.75"
}
],
"gamma_profile": {
"ticker": "BBIO",
"spot": 72.44,
"date": "2026-09-11",
"flip_point": 71.2,
"net_gex": 10734.57,
"call_walls": [
{
"strike": 72.5,
"gex": 8886.52
},
{
"strike": 75.0,
"gex": 5973.06
},
{
"strike": 70.0,
"gex": 4579.77
}
],
"put_walls": [
{
"strike": 62.5,
"gex": -8640.73
},
{
"strike": 75.0,
"gex": -7526.95
},
{
"strike": 70.0,
"gex": -2713.31
}
],
"by_strike": [
{
"strike": 42.5,
"call_gex": 20.93,
"put_gex": -2.17,
"net_gex": 18.76
},
{
"strike": 45.0,
"call_gex": 927.08,
"put_gex": -1909.23,
"net_gex": -982.15
},
{
"strike": 47.5,
"call_gex": 31.91,
"put_gex": -0.85,
"net_gex": 31.05
},
{
"strike": 50.0,
"call_gex": 308.3,
"put_gex": -172.96,
"net_gex": 135.34
},
{
"strike": 52.5,
"call_gex": 0.54,
"put_gex": 0.0,
"net_gex": 0.54
},
{
"strike": 55.0,
"call_gex": 303.37,
"put_gex": -383.08,
"net_gex": -79.7
},
{
"strike": 57.5,
"call_gex": 1.22,
"put_gex": -80.91,
"net_gex": -79.69
},
{
"strike": 60.0,
"call_gex": 1520.84,
"put_gex": -41.15,
"net_gex": 1479.69
},
{
"strike": 62.5,
"call_gex": 26.85,
"put_gex": -8640.73,
"net_gex": -8613.88
},
{
"strike": 65.0,
"call_gex": 3075.37,
"put_gex": -1096.35,
"net_gex": 1979.02
},
{
"strike": 67.5,
"call_gex": 55.12,
"put_gex": -34.83,
"net_gex": 20.29
},
{
"strike": 70.0,
"call_gex": 4579.77,
"put_gex": -2713.31,
"net_gex": 1866.46
},
{
"strike": 72.5,
"call_gex": 8886.52,
"put_gex": -245.2,
"net_gex": 8641.33
},
{
"strike": 75.0,
"call_gex": 5973.06,
"put_gex": -7526.95,
"net_gex": -1553.89
},
{
"strike": 77.5,
"call_gex": 983.39,
"put_gex": -696.95,
"net_gex": 286.44
},
{
"strike": 80.0,
"call_gex": 2123.38,
"put_gex": -2050.82,
"net_gex": 72.57
},
{
"strike": 82.5,
"call_gex": 861.78,
"put_gex": -97.96,
"net_gex": 763.83
},
{
"strike": 85.0,
"call_gex": 1771.57,
"put_gex": -215.21,
"net_gex": 1556.36
},
{
"strike": 87.5,
"call_gex": 551.98,
"put_gex": -3.92,
"net_gex": 548.06
},
{
"strike": 90.0,
"call_gex": 1141.4,
"put_gex": -83.87,
"net_gex": 1057.53
},
{
"strike": 92.5,
"call_gex": 43.08,
"put_gex": -1.51,
"net_gex": 41.57
},
{
"strike": 95.0,
"call_gex": 1186.56,
"put_gex": -1.74,
"net_gex": 1184.81
},
{
"strike": 97.5,
"call_gex": 10.47,
"put_gex": -0.64,
"net_gex": 9.83
},
{
"strike": 100.0,
"call_gex": 553.07,
"put_gex": -1.87,
"net_gex": 551.21
},
{
"strike": 105.0,
"call_gex": 234.6,
"put_gex": 0.0,
"net_gex": 234.6
}
]
},
"oi_changes": {
"net_call_oi_change": 286,
"net_put_oi_change": 0,
"top": [
{
"strike": "45",
"oi_change": 200,
"type": "call"
},
{
"strike": "72.5",
"oi_change": 84,
"type": "call"
},
{
"strike": "60",
"oi_change": 2,
"type": "call"
},
{
"strike": "45",
"oi_change": 0,
"type": "put"
},
{
"strike": "62.5",
"oi_change": 0,
"type": "put"
}
]
},
"opds": {
"opds": 6.6,
"D": 48.0,
"P": -91.3,
"O": 4.8,
"C": 13.7,
"signal": "NEUTRAL",
"direction": "bullish",
"coverage": 0.85,
"ranked": true,
"components": {
"M": -69.4,
"T": -100.0,
"RS": -59.4,
"V": -150.6,
"F": -44.0,
"OI": 100.0,
"S": 6.5,
"IV": -22.0,
"B": null,
"Liquidity": 0.0,
"OpeningConfidence": 0.0,
"FlowAgreement": 50.0,
"StrikeBreadth": 16.7
},
"drivers": [
"- price/volume -151",
"+ open-interest change +100",
"- trend -100",
"- momentum -69",
"- relative strength -59"
]
}
}
Data:
{
"vix": 15.72,
"sp500": 7673.52,
"fed_funds": 3.63,
"yield_curve_10y2y": 0.41,
"hy_spread": 2.68,
"treasury": {
"date": "2026-09-09",
"month1": 3.81,
"month2": 3.93,
"month3": 3.95,
"month6": 4.01,
"year1": 4.17,
"year2": 4.43,
"year3": 4.49,
"year5": 4.61,
"year7": 4.71,
"year10": 4.83,
"year20": 5.28,
"year30": 5.28
},
"events": []
}
Data:
{
"days": 105,
"patterns": [
{
"name": "VWAP Touch",
"count": 105,
"pct": 100
},
{
"name": "9 EMA Touch",
"count": 105,
"pct": 100
},
{
"name": "21 EMA Touch",
"count": 105,
"pct": 100
},
{
"name": "ORB Breakout",
"count": 102,
"pct": 97
},
{
"name": "Woodie Pivot Touch",
"count": 99,
"pct": 94
},
{
"name": "PDH/PDL Touch",
"count": 92,
"pct": 88
},
{
"name": "Gap Fill",
"count": 80,
"pct": 76
},
{
"name": "Open Retracement",
"count": 70,
"pct": 67
},
{
"name": "Darvas Box",
"count": 64,
"pct": 61
},
{
"name": "High Vol Open",
"count": 30,
"pct": 29
},
{
"name": "Power Hour",
"count": 13,
"pct": 12
}
]
}